Brendan DeCenso
Overview
Explore the profile of Brendan DeCenso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
474
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wollum A, Dansereau E, Fullman N, Achan J, Bannon K, Burstein R, et al.
BMC Health Serv Res
. 2017 Aug;
17(1):564.
PMID: 28814295
Background: Considerable debate exists concerning the effects of antiretroviral therapy (ART) service scale-up on non-HIV services and overall health system performance in sub-Saharan Africa. In this study, we examined whether...
2.
DeCenso B, Duber H, Flaxman A, Murphy S, Hanlon M
Health Serv Res
. 2017 Mar;
53(2):974-990.
PMID: 28295278
Objective: To assess the changes in patient outcome prediction and hospital performance ranking when incorporating diagnoses as risk adjusters rather than comorbidity indices. Data Sources: Healthcare Cost and Utilization Project...
3.
Dieleman J, Baral R, Birger M, Bui A, Bulchis A, Chapin A, et al.
JAMA
. 2016 Dec;
316(24):2627-2646.
PMID: 28027366
Importance: US health care spending has continued to increase, and now accounts for more than 17% of the US economy. Despite the size and growth of this spending, little is...
4.
Di Giorgio L, Moses M, Fullman N, Wollum A, Conner R, Achan J, et al.
BMC Med
. 2016 Jul;
14(1):108.
PMID: 27439621
Background: Since 2000, international funding for HIV has supported scaling up antiretroviral therapy (ART) in sub-Saharan Africa. However, such funding has stagnated for years, threatening the sustainability and reach of...
5.
Odeny T, DeCenso B, Dansereau E, Gasasira A, Kisia C, Njuguna P, et al.
J Int AIDS Soc
. 2015 Oct;
18:20019.
PMID: 26507824
Introduction: Understanding the determinants of timely antiretroviral therapy (ART) initiation is useful for HIV programmes intent on developing models of care that reduce delays in treatment initiation while maintaining a...
6.
Dansereau E, Gakidou E, Ng M, Achan J, Burstein R, DeCenso B, et al.
PLoS One
. 2015 Aug;
10(8):e0135653.
PMID: 26275151
Introduction: Patients receiving antiretroviral therapy (ART) require routine monitoring to track response to treatment and assess for treatment failure. This study aims to identify gaps in monitoring practices in Kenya...
7.
Duber H, Dansereau E, Masters S, Achan J, Burstein R, DeCenso B, et al.
PLoS One
. 2015 Mar;
10(3):e0120350.
PMID: 25807553
Introduction: Antiretroviral therapy (ART) guidelines were significantly changed by the World Health Organization in 2010. It is largely unknown to what extent these guidelines were adopted into clinical practice. Methods:...
8.
Masters S, Burstein R, DeCenso B, Moore K, Haakenstad A, Ikilezi G, et al.
PLoS One
. 2014 Dec;
9(12):e114762.
PMID: 25500832
Objective: In this study we use facility-level data from nationally representative surveys conducted in Ghana, Kenya, and Uganda to understand pharmaceutical availability within the three countries. Methods: In 2012, we...